🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to learn if the study drug mocetinostat can sl...
Status
Terminated
Location
Memorial Sloan Kettering Cancer Center
Start Date
2014-10
Trial ID
NCT02282358
Treatments Being Tested
The purpose of this study is to test the combination of an experimental dru...
Status
Terminated
Location
Johns Hopkins, Sidney Kimmel Comprehensive Cancer Center
Start Date
2007-08
Trial ID
NCT00511576
Treatments Being Tested
MGCD0103 is an experimental drug that belongs to a class of drugs known as ...
Status
Terminated
Location
Rush University Medical Center
Start Date
2006-08
Trial ID
NCT00358982
Treatments Being Tested
This is a Phase 1b, open-label, dose-escalation cohort study. The study wil...
Status
Terminated
Location
New York University School of Medicine
Start Date
2018-04-25
Trial ID
NCT03565406
In this study, MGCD0103, a new anticancer drug under investigation, is give...
Status
Completed
Location
University of Southern California
Start Date
2006-01
Trial ID
NCT00324220
Treatments Being Tested
In this study, MGCD0103, a new anticancer drug under investigation, is give...
Status
Completed
Location
Veteran Affairs Medical Center Research Service
Start Date
2007-01
Trial ID
NCT00431873
Treatments Being Tested
In this study, MGCD0103, a new anticancer drug under investigation, is give...
Status
Completed
Location
Duke University Adult Bone Marrow Transplant Clinic
Start Date
2006-08
Trial ID
NCT00359086
Treatments Being Tested
In this study, MGCD0103, a new anticancer drug under investigation, is give...
Status
Completed
Location
The Johns Hopkins Hospital
Start Date
2004-04
Trial ID
NCT00323934
Treatments Being Tested
Mocetinostat is an orally administered histone deacetylase (HDAC) inhibitor...
Status
Completed
Location
University of Alabama
Start Date
2014-10
Trial ID
NCT02236195
Treatments Being Tested
In this study, MGCD0103, a new anticancer drug under investigation, is give...
Status
Completed
Location
Lee Moffitt Cancer Center
Start Date
2005-02
Trial ID
NCT00324194
Treatments Being Tested